Results 91 to 100 of about 53,405 (189)

Imatinib Mesylate Reduces Voiding Frequency in Female Mice With Acute Cyclophosphamide-Induced Cystitis. [PDF]

Front Syst Neurosci, 2022
Perkins ME, Girard BM, Campbell SE, Vizzard MA.   +3 more
europepmc   +1 more source

Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate - The impact of fibrosarcomatous transformation.

European Journal of Surgical Oncology, 2017
P. Rutkowski, A. Klimczak, I. Ługowska, B. Jagielska, M. Wągrodzki, M. Debiec-Rychter, B. Pieńkowska-Grela, T. Switaj   +7 more
semanticscholar   +1 more source

A rare complication of imatinib mesylate therapy: drug-induced pneumonitis

Терапевтический архив, 2010
The use of imatinib mesylate (Glivec®) (Novartis Pharma AG, Switzerland) that is the drug of choice in treating patients with chronic myeloid leukemia (CML) has increased 7-year survival and improved the prognosis of the disease.
Ol'ga Veniaminovna Stakhina, A G Turkina, I E Kostina, Yu B Kochkareva, O V Stakhina, A G Turkina, I E Kostina, Yu B Kochkareva   +7 more
doaj  

Imatinib Mesylate Induces Necroptotic Cell Death and Impairs Autophagic Flux in Human Cardiac Progenitor Cells. [PDF]

Int J Mol Sci, 2022
Walmsley R, Steele DS, Ellison-Hughes GM, Papaspyros S, Smith AJ.   +4 more
europepmc   +1 more source

In vitro effect of imatinib mesylate loaded on polybutylcyanoacrylate nanoparticles on leukemia cell line K562

Artificial Cells Nanomedicine and Biotechnology, 2017
Leyla Hasandoost, A. Akbarzadeh, Hossein Attar, A. Heydarinasab   +3 more
semanticscholar   +1 more source

Modulation of Plasma 25-Hydroxyvitamin D3 Level by Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia: The Role of Uptake and Efflux Transporters. [PDF]

Curr Ther Res Clin Exp, 2022
Omran MM, Shouman SA, Abdelfattah R, Moussa HS, Thabet NA, Hamza MS.   +5 more
europepmc   +1 more source

Imatinib Mesylate-Loaded Rosin/Cinnamon Oil-Based In Situ Forming Gel against Colorectal Cancer Cells. [PDF]

Gels, 2022
Khaing EM, Intaraphairot T, Mahadlek J, Okonogi S, Pichayakorn W, Phaechamud T.   +5 more
europepmc   +1 more source

Imatinib Mesylate Reduces Neurotrophic Factors and pERK and pAKT Expression in Urinary Bladder of Female Mice With Cyclophosphamide-Induced Cystitis. [PDF]

Front Syst Neurosci, 2022
Perkins M, Girard BM, Campbell SE, Hennig GW, Vizzard MA.   +4 more
europepmc   +1 more source

Imatinib Mesylate [PDF]

, 2020
openaire   +1 more source

Erratum: [Corrigendum] Imatinib mesylate and nilotinib decrease synthesis of bone matrix <i>in vitro</i>. [PDF]

Oncol Lett
Kroschwald LM, Tauer JT, Kroschwald SI, Suttorp M, Wiedenfeld A, Beissert S, Bauer A, Rauner M.   +7 more
europepmc   +1 more source